Other Pharmaceuticals and Biotechnology · San Francisco, CA · Founded 2019 · Privately Held (backing)
Developer of a drug discovery tool designed to accelerate the development of prescription and nonprescription health products targeting the endocannabinoid system (ECS). Nalu Bio is based in San Francisco, CA and was founded in 2019. It has raised $13.5 million across 2 recorded rounds; the latest was an accelerator round in Mar 2025.
Last price · $/share
—
Implied valuation
—
Total raised
$13.5M
Last round
Accelerator/Incubator
Mar 2025
Team — not yet on record
No current team members for Nalu Bio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Nalu Bio with a free account
·Watch Nalu Bio: the Monday email on marks, rounds and moves
